Healthcare & Medical Equipment Suppliers Sector Financials, Performance and Ratios
-
Sector Score
36.0 /100
Rank 17 out of 27 Sectors -
Advance/Decline
146/64
-
No. of Companies210
-
Avg. Market Cap9,291
-
Price to Earning Ratio31.02
-
Price to Earning Growth Ratio2.87
-
Price to Book Ratio5.87
-
Return on Equity48.23
-
Return on Capital Employed-
-
Return on Assets6.04
-
Dividend yield 1 year %0.27 %
-
Net Profit Growth Annual YoY %-4.05 %
-
Net Profit Growth Qtr YoY %15.28 %
-
Net Profit Growth Qtr QoQ %-1.41 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Healthcare & Medical Equipment Suppliers Sector Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Healthcare & Medical Equipment Suppliers Peer comparison
Compare all stocks in Healthcare & Medical Equipment Suppliers industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Tech |
|
37,176.5
|
131.6
|
L
 3.9%
H
128.2
132.7
|
L
 2.6%
H
123.7
132.7
|
L
 14.5%
H
113.3
141.1
|
L
 17.5%
H
108.4
141.1
|
L
 13.4%
H
108.4
160.3
|
L
 10.2%
H
96.4
160.3
|
L
 -10.6%
H
96.4
179.6
|
L
 182.0%
H
42.0
179.6
|
| Amerisource Bergen Corp |
|
-
|
284.5
|
L
 1.2%
H
281.1
288.5
|
L
 1.1%
H
269.3
288.5
|
L
 3.5%
H
261.3
288.5
|
L
 -11.3%
H
244.8
329.0
|
L
 -3.0%
H
244.8
377.5
|
L
 51.6%
H
174.2
377.5
|
L
 145.6%
H
111.3
377.5
|
L
 266.8%
H
68.4
377.5
|
| Abbott |
|
157,616.7
|
90.5
|
L
 0.0%
H
90.3
92.9
|
L
 -0.1%
H
87.2
92.9
|
L
 3.5%
H
85.0
92.9
|
L
 -13.7%
H
82.0
106.0
|
L
 -32.1%
H
82.0
139.1
|
L
 -16.3%
H
82.0
141.2
|
L
 -18.4%
H
82.0
142.6
|
L
 128.3%
H
36.8
142.6
|
| Alcon Inc - Registered Shares |
|
33,129.5
|
67.9
|
L
 2.7%
H
67.2
68.4
|
L
 3.2%
H
63.8
68.4
|
L
 0.2%
H
63.8
68.4
|
L
 -8.4%
H
61.8
82.4
|
L
 -20.4%
H
61.8
92.6
|
L
 -15.6%
H
61.8
101.1
|
L
 -3.0%
H
55.2
101.1
|
L
H
39.4
101.1
|
| Artivion Inc |
|
1,069.4
|
22.0
|
L
 6.5%
H
20.7
22.1
|
L
 2.7%
H
20.1
22.1
|
L
 -1.9%
H
19.8
23.6
|
L
 -38.3%
H
19.2
39.7
|
L
 -28.6%
H
19.2
48.3
|
L
 39.2%
H
12.2
48.3
|
L
 -25.2%
H
9.6
48.3
|
L
 84.5%
H
9.6
48.3
|
| Avanos Medical Inc |
|
1,168.9
|
25.0
|
L
 0.1%
H
24.9
25.0
|
L
 0.0%
H
24.9
25.0
|
L
 1.4%
H
24.7
25.5
|
L
 86.2%
H
13.3
25.5
|
L
 106.0%
H
9.3
25.5
|
L
 -3.6%
H
9.3
26.6
|
L
 -34.9%
H
9.3
39.0
|
L
 -25.5%
H
9.3
73.0
|
| Baxter International |
|
10,866.5
|
21.0
|
L
 4.7%
H
20.3
21.1
|
L
 2.8%
H
19.4
21.1
|
L
 9.7%
H
18.1
21.3
|
L
 26.7%
H
15.7
21.3
|
L
 -29.8%
H
15.7
31.8
|
L
 -53.3%
H
15.7
50.2
|
L
 -74.0%
H
15.7
89.7
|
L
 -54.2%
H
15.7
95.2
|
| Becton, Dickinson and Co. |
|
40,716.6
|
147.8
|
L
 2.7%
H
144.6
149.2
|
L
 1.8%
H
140.1
149.2
|
L
 0.1%
H
140.1
153.2
|
L
 -5.4%
H
140.1
160.2
|
L
 -12.9%
H
140.1
213.1
|
L
 -42.4%
H
140.1
287.3
|
L
 -36.9%
H
140.1
287.3
|
L
 -12.0%
H
140.1
287.3
|
| Butterfly Network Inc (Class A) |
|
2,032.9
|
7.8
|
L
 1.3%
H
7.7
8.3
|
L
 37.5%
H
5.6
8.9
|
L
 73.8%
H
4.4
8.9
|
L
 85.4%
H
3.7
8.9
|
L
 279.0%
H
1.3
8.9
|
L
 270%
H
0.7
8.9
|
L
 -43.6%
H
0.7
14.7
|
L
H
0.7
29.1
|
| Bio-Rad Laboratories Inc (Class A) |
|
7,494.6
|
280.1
|
L
 3.6%
H
270
284.0
|
L
 -3.4%
H
270
293.1
|
L
 -2.7%
H
270
319.9
|
L
 5.7%
H
236.7
319.9
|
L
 18.9%
H
235.0
343.1
|
L
 -23.4%
H
211.4
431.8
|
L
 -55.3%
H
211.4
832.7
|
L
 96.7%
H
135.9
832.7
|
| Bausch + Lomb Corp |
|
5,529.9
|
15.5
|
L
 1.8%
H
15.3
15.9
|
L
 3.5%
H
14.7
15.9
|
L
 -2.6%
H
14.7
16.0
|
L
 -2.1%
H
14.7
17.1
|
L
 29.3%
H
11.9
18.9
|
L
 -19.8%
H
10.5
22.0
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
| Boston Scientific |
|
66,083.4
|
44.5
|
L
 -2.5%
H
44.1
45.8
|
L
 -5.2%
H
44.1
46.7
|
L
 -23.1%
H
44.1
58.1
|
L
 -36.1%
H
44.1
71.2
|
L
 -56.6%
H
44.1
109.5
|
L
 -17.6%
H
44.1
109.5
|
L
 1.5%
H
35.0
109.5
|
L
 93.6%
H
19.7
109.5
|
| Cardinal Health |
|
54,572.3
|
233.0
|
L
 1.8%
H
229.4
235.7
|
L
 2.3%
H
219.5
235.7
|
L
 16.1%
H
194
235.7
|
L
 12.9%
H
180.5
235.7
|
L
 42.1%
H
137.8
235.7
|
L
 154.0%
H
85.1
235.7
|
L
 314.0%
H
45.9
235.7
|
L
 198.3%
H
39.1
235.7
|
| Conmed Corp |
|
1,065.9
|
35.4
|
L
 4.7%
H
34.1
35.7
|
L
 2.4%
H
31.4
35.7
|
L
 -4.9%
H
31.4
37.5
|
L
 -3.4%
H
31.4
40.6
|
L
 -31.5%
H
31.4
56.6
|
L
 -73.2%
H
31.4
138.3
|
L
 -75.1%
H
31.4
159.1
|
L
 -22.2%
H
31.4
159.1
|
| Cooper Companies |
|
13,424.0
|
68.8
|
L
 4.1%
H
66.4
69.3
|
L
 2.2%
H
64.9
69.3
|
L
 10.0%
H
59.1
69.3
|
L
 -2.0%
H
58.9
72.6
|
L
 -1.0%
H
58.9
89.8
|
L
 -26.1%
H
58.9
112.4
|
L
 -29.0%
H
58.9
115.9
|
L
 65.3%
H
39.7
115.9
|
| Danaher |
|
133,676.6
|
188.9
|
L
 5.5%
H
179.9
189.5
|
L
 4.2%
H
174.2
189.5
|
L
 9.8%
H
169.9
189.5
|
L
 -0.6%
H
160.9
200.5
|
L
 -3.8%
H
160.9
242.8
|
L
 -20.7%
H
160.9
281.7
|
L
 -29.7%
H
160.9
334.0
|
L
 148.1%
H
73.4
334.0
|
| Edwards Lifesciences |
|
51,626.2
|
89.7
|
L
 3.1%
H
87
91.0
|
L
 1.2%
H
85.3
91.0
|
L
 4.5%
H
83.2
91.0
|
L
 9.3%
H
76.5
91.0
|
L
 19.0%
H
72.3
91.0
|
L
 -0.8%
H
58.9
96.1
|
L
 -14.4%
H
58.9
131.7
|
L
 171.5%
H
27.0
131.7
|
| Glaukos Corp |
|
8,091.2
|
137.8
|
L
 2.3%
H
133.0
140.8
|
L
 8.0%
H
125.4
140.8
|
L
 14.6%
H
99.5
140.8
|
L
 28.9%
H
99.5
148.1
|
L
 42.3%
H
73.2
148.1
|
L
 104.2%
H
59.2
163.7
|
L
 59.5%
H
33.3
163.7
|
L
 379.2%
H
23.1
163.7
|
| Globus Medical Inc (Class A) |
|
11,147.3
|
82.1
|
L
 2.6%
H
80.9
83.6
|
L
 5.9%
H
74.7
83.6
|
L
 -3.2%
H
74.7
85.8
|
L
 -5.8%
H
74.5
97.4
|
L
 42.1%
H
51.8
101.4
|
L
 40.5%
H
43.4
101.4
|
L
 10.5%
H
43.4
101.4
|
L
 243.5%
H
19.3
101.4
|
| Haemonetics Corp |
|
3,311.6
|
72.9
|
L
 0.1%
H
72.3
75.0
|
L
 -2.1%
H
72.3
75.0
|
L
 11.3%
H
64.5
82.0
|
L
 24.7%
H
51
82.0
|
L
 1.1%
H
47.3
87.3
|
L
 -13.6%
H
47.3
98.0
|
L
 14.3%
H
43.5
98.0
|
L
 141.5%
H
28.2
142.1
|
| Herbalife Nutrition Ltd |
|
1,292.8
|
12.5
|
L
 1.7%
H
12.3
12.7
|
L
 5.5%
H
11.5
12.7
|
L
 0.3%
H
11.2
12.8
|
L
 -15.3%
H
11.2
17.5
|
L
 52.6%
H
7.6
20.4
|
L
 -1.3%
H
5.0
20.4
|
L
 -76.2%
H
5.0
55.4
|
L
 -60.0%
H
5.0
61.8
|
| Inspire Medical Systems Inc |
|
1,244.7
|
43.2
|
L
 3.5%
H
42
43.5
|
L
 4.4%
H
39.7
43.5
|
L
 -1.5%
H
38.9
44.5
|
L
 -17.2%
H
38.9
59.0
|
L
 -66.8%
H
38.9
147.0
|
L
 -86.3%
H
38.9
330
|
L
 -78.3%
H
38.9
330
|
L
H
22.5
330
|
| Integer Holdings Corp |
|
3,102.8
|
91.4
|
L
 2.1%
H
89.1
92.3
|
L
 0.1%
H
87.0
92.8
|
L
 2.4%
H
87.0
94.8
|
L
 7.1%
H
77.1
94.8
|
L
 -23.3%
H
62
123.8
|
L
 6.2%
H
62
146.4
|
L
 -1.9%
H
50.1
146.4
|
L
 187.0%
H
18.1
146.4
|
| McKesson |
|
89,745.9
|
766.6
|
L
 0.4%
H
762.4
777.8
|
L
 -2.4%
H
744.5
784.7
|
L
 0.1%
H
729.2
800.4
|
L
 -12.6%
H
723.7
892.2
|
L
 6.2%
H
637
999
|
L
 84.4%
H
395.3
999
|
L
 305.9%
H
186.6
999
|
L
 316.6%
H
106.1
999
|
| Medtronic |
|
102,570.0
|
80.1
|
L
 -0.6%
H
80.1
82.1
|
L
 -1.5%
H
77.6
82.1
|
L
 2.0%
H
73.3
82.8
|
L
 -8.1%
H
73.3
89.2
|
L
 -6.8%
H
73.3
106.3
|
L
 -8.4%
H
68.9
106.3
|
L
 -36.1%
H
68.9
135.9
|
L
 -6.6%
H
68.9
135.9
|
| Mettler-Toledo International |
|
24,313.4
|
1,203.2
|
L
 4.0%
H
1167.1
1219.5
|
L
 4.5%
H
1121.1
1219.5
|
L
 9.1%
H
1088.5
1219.5
|
L
 -2.9%
H
1023.1
1365.8
|
L
 3.4%
H
1023.1
1525.2
|
L
 -6.6%
H
928.5
1546.9
|
L
 -11.3%
H
928.5
1714.8
|
L
 215.3%
H
343.6
1714.8
|
| Envista Holdings Corp |
|
4,237.4
|
26.0
|
L
 3.1%
H
25.6
26.2
|
L
 5.2%
H
24.7
26.2
|
L
 11.1%
H
22.4
26.2
|
L
 0.9%
H
22.4
29.5
|
L
 37.8%
H
18.7
30.4
|
L
 -22.3%
H
14.2
36.1
|
L
 -39.2%
H
14.2
52.0
|
L
H
10.1
52.0
|
| Owens & Minor Inc |
|
245.1
|
3.2
|
L
 2.2%
H
3.1
3.4
|
L
 4.2%
H
3.0
3.4
|
L
 13.1%
H
2.5
3.4
|
L
 56.9%
H
2.0
4.7
|
L
 -56.0%
H
1.8
9.6
|
L
 -82.8%
H
1.8
28.4
|
L
 -92.4%
H
1.8
49.1
|
L
 -91.6%
H
1.8
49.2
|
| Penumbra Inc |
|
12,442.9
|
316.4
|
L
 -0.4%
H
316.3
318.8
|
L
 -0.7%
H
315.0
318.8
|
L
 -3.8%
H
315.0
329.7
|
L
 -5.7%
H
315.0
337.8
|
L
 24.3%
H
221.3
362.4
|
L
 -5.3%
H
148
362.4
|
L
 13.0%
H
114.9
362.4
|
L
 427.3%
H
55.0
362.4
|
| Koninklijke Philips N.V. (ADR) |
|
25,981.1
|
26.7
|
L
 0.5%
H
26.7
26.9
|
L
 -0.3%
H
26.1
27.2
|
L
 -0.8%
H
25.3
27.3
|
L
 -0.3%
H
25.1
30.0
|
L
 17.9%
H
23.5
33.4
|
L
 31.5%
H
17.8
33.4
|
L
 -46.6%
H
11.8
50.7
|
L
 1.2%
H
11.8
61.2
|
| Qiagen NV |
|
7,988.1
|
38.7
|
L
 4.1%
H
38.3
39.2
|
L
 4.1%
H
36.2
39.2
|
L
 10.1%
H
35.1
39.2
|
L
 -1.9%
H
32.5
42.3
|
L
 -21.2%
H
32.5
57.8
|
L
 -23.3%
H
32.5
57.8
|
L
 -26.7%
H
32.5
64.7
|
L
 49.2%
H
23.1
65.9
|
| ResMed |
|
28,503.6
|
196.5
|
L
 2.7%
H
192.4
197.6
|
L
 1.3%
H
184.7
197.6
|
L
 -5.6%
H
180.3
211.6
|
L
 -13.8%
H
180.3
234.9
|
L
 -22.8%
H
180.3
293.8
|
L
 -8.7%
H
132.2
293.8
|
L
 -19.3%
H
132.2
301.3
|
L
 206.6%
H
56.6
301.3
|
| Steris PLC |
|
20,190.3
|
207.2
|
L
 2.0%
H
203.4
208.9
|
L
 0.3%
H
198.0
208.9
|
L
 -4.3%
H
198.0
217.9
|
L
 -6.3%
H
195.1
227.9
|
L
 -12.6%
H
195.1
269.4
|
L
 -1.7%
H
195.1
269.4
|
L
 0.8%
H
159.2
269.4
|
L
 198.6%
H
63.3
269.4
|
| Stevanato Grp Spa |
|
4,706.6
|
17.2
|
L
 2.2%
H
16.9
17.4
|
L
 4.4%
H
16.5
18.0
|
L
 -4.3%
H
16.3
19.8
|
L
 16.5%
H
12.9
19.8
|
L
 -26.5%
H
12.9
28
|
L
 -46.3%
H
12.9
36.3
|
L
H
12.9
36.3
|
L
H
12.9
36.3
|
| Stryker |
|
120,252.6
|
313.7
|
L
 1.2%
H
311.6
319.5
|
L
 1%
H
299.2
319.5
|
L
 -0.9%
H
291.0
319.5
|
L
 -5.7%
H
281
352.8
|
L
 -17.3%
H
281
404.9
|
L
 5.3%
H
250.0
406.2
|
L
 19.4%
H
188.8
406.2
|
L
 165.0%
H
106.5
406.2
|
| Smith & Nephew PLC (ADR) |
|
12,800.9
|
30.3
|
L
 2.2%
H
30.2
30.6
|
L
 -0.8%
H
29.4
30.6
|
L
 -0.9%
H
29.1
31.4
|
L
 -5.3%
H
29.1
34.7
|
L
 3.7%
H
29.1
38.8
|
L
 -3.4%
H
21.5
38.8
|
L
 -29.9%
H
21.5
44.3
|
L
 -12.7%
H
21.5
52.3
|
| Teleflex Incorporated |
|
5,600.6
|
126.5
|
L
 1.8%
H
124.8
127.6
|
L
 -1.1%
H
120.9
129.2
|
L
 -4.7%
H
120.9
136.6
|
L
 19.5%
H
103.1
139.7
|
L
 7.2%
H
100.2
139.7
|
L
 -46.7%
H
100.2
263.0
|
L
 -69.0%
H
100.2
428.4
|
L
 -28.4%
H
100.2
449.4
|
| Thermo Fisher |
|
182,912.1
|
492.2
|
L
 4.9%
H
473.5
493
|
L
 4.1%
H
457.6
493
|
L
 9.8%
H
443.6
499
|
L
 2.9%
H
435.3
538.4
|
L
 23.0%
H
398.1
644.0
|
L
 -6.1%
H
385.5
644.0
|
L
 -0.4%
H
385.5
672.3
|
L
 223.5%
H
139.1
672.3
|
| Waters |
|
36,248.3
|
369.2
|
L
 3.4%
H
362.2
377.2
|
L
 2.4%
H
351.8
377.2
|
L
 7.8%
H
334.2
385.3
|
L
 22.3%
H
287.2
385.3
|
L
 7.7%
H
275.1
414.2
|
L
 42.1%
H
231.9
423.6
|
L
 6.4%
H
231.9
428.2
|
L
 166.7%
H
131.4
428.2
|
| West Pharma Services |
|
24,049.1
|
340.4
|
L
 1.2%
H
335.7
346.0
|
L
 3.3%
H
321.9
346.0
|
L
 7.6%
H
308.2
346.0
|
L
 41.0%
H
238.8
346.0
|
L
 57.1%
H
206.8
346.0
|
L
 -7.2%
H
187.4
415.7
|
L
 -5.1%
H
187.4
475.4
|
L
 349.3%
H
70.2
475.4
|
| Zimmer Biomet Holdings |
|
17,520.0
|
90.6
|
L
 3.4%
H
88.0
90.6
|
L
 1.4%
H
86.6
90.6
|
L
 5.9%
H
81.6
90.6
|
L
 3.1%
H
79.1
97.8
|
L
 -1.0%
H
79.1
108.3
|
L
 -37.1%
H
79.1
147.5
|
L
 -41.5%
H
79.1
157.7
|
L
 -20.4%
H
70.0
169.7
|
| BioRad Laboratories Inc |
|
8,535.7
|
296.5
|
L
 2.2%
H
292.0
296.5
|
L
 -2.5%
H
289.2
298.0
|
L
 10.9%
H
289.2
304.2
|
L
 10.4%
H
244.5
304.2
|
L
 18.6%
H
244.5
321.1
|
L
 -10.7%
H
225.3
373.4
|
L
 -10.7%
H
225.3
373.4
|
L
 -10.7%
H
225.3
373.4
|
| Haleon PLC (ADR) |
|
40,679.3
|
9.2
|
L
 3.1%
H
9.2
9.3
|
L
 1.5%
H
8.8
9.3
|
L
 -0.7%
H
8.7
9.4
|
L
 -7.1%
H
8.7
10.1
|
L
 -12.0%
H
8.7
11.3
|
L
 9.6%
H
7.7
11.4
|
L
H
5.6
11.4
|
L
H
5.6
11.4
|
| Revvity |
|
11,784.1
|
105.6
|
L
 5.7%
H
101.5
106.9
|
L
 4.4%
H
96.9
106.9
|
L
 9.0%
H
95.3
106.9
|
L
 21.2%
H
81.2
106.9
|
L
 11.3%
H
81.2
118.3
|
L
 -8.9%
H
79.5
132.0
|
L
 -31.7%
H
79.5
203.2
|
L
 94.8%
H
45.4
203.2
|
| Aethlon Medical Inc |
|
2.9
|
1.2
|
L
 -10.3%
H
1.2
1.4
|
L
 -36.8%
H
1.2
2.0
|
L
 -44.6%
H
1.2
3.2
|
L
 -47.0%
H
1.2
3.2
|
L
 -91.3%
H
1.2
27.4
|
L
 -99.6%
H
1.2
400
|
L
 -100.0%
H
1.2
4976
|
L
 -100.0%
H
1.2
109078.8
|
| Ainos Inc |
|
13.3
|
1.8
|
L
 -2.7%
H
1.8
2.0
|
L
 -4.3%
H
1.8
2.2
|
L
 17.7%
H
1.5
3.9
|
L
 12.5%
H
1.3
3.9
|
L
 -27.4%
H
1.3
4.5
|
L
 -89.8%
H
1.3
30.5
|
L
 -99.6%
H
1.3
525
|
L
 373.7%
H
0.1
1781.3
|
| Airsculpt Tech Inc |
|
320.3
|
4.5
|
L
 -1.3%
H
4.5
4.6
|
L
 -9.7%
H
4.5
5.2
|
L
 -14.8%
H
4.5
5.8
|
L
 63.3%
H
2.3
5.8
|
L
 -6.4%
H
1.5
12
|
L
 -41.8%
H
1.5
12
|
L
H
1.5
18.5
|
L
H
1.5
18.5
|
| Align Tech |
|
12,239.5
|
170.9
|
L
 1.4%
H
165.5
174.4
|
L
 -4.8%
H
165.5
185
|
L
 4.5%
H
160.3
185
|
L
 -5.5%
H
151.6
200.4
|
L
 -6.8%
H
122
208.3
|
L
 -48.0%
H
122
413.2
|
L
 -71.8%
H
122
737.5
|
L
 108.9%
H
77.1
737.5
|
| Angiodynamic Inc |
|
535.1
|
13.0
|
L
 4.7%
H
12.4
13.2
|
L
 6.6%
H
11.6
13.2
|
L
 8.6%
H
10.9
13.2
|
L
 20.9%
H
9.4
13.2
|
L
 29.6%
H
8.4
14.0
|
L
 19.2%
H
5.3
14.0
|
L
 -52.9%
H
5.3
32
|
L
 -7.2%
H
5.3
32
|
| Anika Therapeutics Inc |
|
196.0
|
14.7
|
L
 1.0%
H
14.3
14.9
|
L
 3.0%
H
13.8
14.9
|
L
 -1.0%
H
13.8
15.8
|
L
 3.2%
H
11.9
16.2
|
L
 34.9%
H
7.9
16.2
|
L
 -44.7%
H
7.9
29.1
|
L
 -66.2%
H
7.9
45.8
|
L
 -71.2%
H
7.9
75.7
|
| Apyx Medical Corp |
|
172.5
|
4.1
|
L
 1.0%
H
4.0
4.3
|
L
 -0.7%
H
3.9
4.3
|
L
 -0.2%
H
3.8
5.1
|
L
 3.5%
H
2.8
5.1
|
L
 106%
H
1.6
5.1
|
L
 -43.6%
H
0.8
8.0
|
L
 -61.6%
H
0.8
17.5
|
L
 149.7%
H
0.8
17.5
|
| Accuray Inc |
|
39.3
|
0.3
|
L
H
0.3
0.4
|
L
 -2.9%
H
0.3
0.4
|
L
 6.5%
H
0.3
0.4
|
L
 -13.2%
H
0.3
0.5
|
L
 -73.6%
H
0.3
2.1
|
L
 -91.0%
H
0.3
4.3
|
L
 -92.7%
H
0.3
5.9
|
L
 -93.7%
H
0.3
6.4
|
| Alphatec Holdings Inc |
|
1,338.0
|
8.7
|
L
 2.4%
H
8.1
9.1
|
L
 3.1%
H
8.1
9.2
|
L
 5.2%
H
7.3
9.2
|
L
 -28.4%
H
6.8
12.2
|
L
 -19.9%
H
6.8
23.3
|
L
 -46.5%
H
4.9
23.3
|
L
 -45.4%
H
4.9
23.3
|
L
 156.6%
H
1.2
23.3
|
| Atricure Inc |
|
1,432.1
|
28.3
|
L
 -0.6%
H
28.1
28.9
|
L
 1.1%
H
26.8
29.0
|
L
 0.0%
H
25.4
29.3
|
L
 -5.0%
H
25.4
30.7
|
L
 -11.4%
H
25.4
43.2
|
L
 -40.9%
H
18.9
59.6
|
L
 -63.5%
H
18.9
89.2
|
L
 87.0%
H
13.5
89.2
|
| Axogen Inc |
|
2,261.1
|
42.5
|
L
 -4.9%
H
41.4
46
|
L
 -2.0%
H
41.4
46
|
L
 4.0%
H
38.1
46
|
L
 33.9%
H
30
46
|
L
 334.3%
H
9.5
46
|
L
 373.0%
H
3.5
46
|
L
 94.2%
H
3.5
46
|
L
 572.8%
H
3.5
56.9
|
| Bone Biologics Corp |
|
2.4
|
1.4
|
L
 -2.2%
H
1.3
1.4
|
L
 -2.2%
H
1.3
1.5
|
L
 10.7%
H
1.2
1.5
|
L
 14.4%
H
1.1
1.5
|
L
 -78.2%
H
1.1
6.2
|
L
 -98.1%
H
1.1
85.0
|
L
 -100.0%
H
1.1
10255.5
|
L
 -100.0%
H
1.1
169920
|
| BioAffinity Tech Inc |
|
5.3
|
0.9
|
L
 1.2%
H
0.8
0.9
|
L
 -9.6%
H
0.8
0.9
|
L
 -45.5%
H
0.8
2.2
|
L
 -82.0%
H
0.8
5.1
|
L
 -87.7%
H
0.7
13.8
|
L
 -98.4%
H
0.7
108.6
|
L
H
0.7
466.5
|
L
H
0.7
466.5
|
| Bluejay Diagnostics Inc |
|
3.1
|
3.0
|
L
 -22.9%
H
2.9
3.9
|
L
 -34.1%
H
2.9
4.9
|
L
 55.7%
H
1.9
7
|
L
 48.8%
H
1.6
7
|
L
 -53.3%
H
1.6
16.7
|
L
 -100.0%
H
1.6
22368
|
L
H
1.6
200000
|
L
H
1.6
200000
|
| Biolife Soln Inc |
|
1,249.3
|
25.6
|
L
 3.2%
H
24.8
26.0
|
L
 -3%
H
24.8
27.4
|
L
 6.8%
H
23.5
28.1
|
L
 33.4%
H
17.9
28.1
|
L
 19.7%
H
17.9
29.6
|
L
 11.1%
H
8.9
29.6
|
L
 -41.9%
H
8.9
60.7
|
L
 1478.4%
H
1.4
60.7
|
| Biomerica Inc |
|
5.4
|
1.8
|
L
 -0.6%
H
1.7
1.8
|
L
 -9.3%
H
1.7
2.1
|
L
 -29.7%
H
1.7
2.5
|
L
 -17.8%
H
1.7
2.5
|
L
 -42.2%
H
1.7
4.6
|
L
 30.6%
H
0.2
4.9
|
L
 -57.7%
H
0.2
7.4
|
L
 24.1%
H
0.2
23.4
|
| Bruker Corp |
|
8,896.1
|
58.4
|
L
 6.0%
H
55.5
58.6
|
L
 4.7%
H
54.3
58.6
|
L
 27.9%
H
45.0
64.5
|
L
 67.6%
H
33.1
64.5
|
L
 50.9%
H
28.5
64.5
|
L
 -19.8%
H
28.5
94.9
|
L
 -20.6%
H
28.5
94.9
|
L
 139.5%
H
19.6
94.9
|
| BioRestorative Therapies Inc |
|
10.2
|
0.4
|
L
 5.3%
H
0.4
0.4
|
L
 14.3%
H
0.4
0.4
|
L
 90.5%
H
0.2
0.7
|
L
 21.2%
H
0.2
0.7
|
L
 -75.6%
H
0.2
1.9
|
L
 -93.0%
H
0.2
7.1
|
L
 -98.7%
H
0.2
32
|
L
 -100.0%
H
0.2
20040
|
| Biosig Tech Inc |
|
81.3
|
0.8
|
L
 -9.3%
H
0.8
0.9
|
L
 -21.2%
H
0.8
1.0
|
L
 -39.1%
H
0.8
1.6
|
L
 -49.4%
H
0.7
1.7
|
L
 -89.5%
H
0.7
14.1
|
L
 -37.1%
H
0.1
14.1
|
L
 -78.6%
H
0.1
14.1
|
L
 -80.1%
H
0.1
14.1
|
| Bioventus Inc (Class A) |
|
643.6
|
9.5
|
L
 2.3%
H
9.4
9.8
|
L
 8.9%
H
8.4
9.8
|
L
 2.4%
H
7.8
9.8
|
L
 5.6%
H
7.8
11.3
|
L
 45.7%
H
5.8
11.3
|
L
 217.7%
H
2.7
14.4
|
L
 -47.0%
H
0.8
19.9
|
L
H
0.8
19.9
|
| Brainsway Ltd (ADR) |
|
577.9
|
14.4
|
L
 0.1%
H
14.2
14.7
|
L
 1.9%
H
13.9
15.1
|
L
 -4.6%
H
13.8
16.1
|
L
 5.0%
H
12.0
17.4
|
L
 401.7%
H
2.8
17.4
|
L
 2382.8%
H
0.5
17.4
|
L
 456.0%
H
0.3
17.4
|
L
H
0.3
17.4
|
| Cardio Diagnostics Holdings Inc |
|
6.0
|
2.0
|
L
 -7.7%
H
2.0
2.2
|
L
 3.6%
H
1.9
2.2
|
L
 26.1%
H
1.6
2.6
|
L
 -9.8%
H
1.3
2.6
|
L
 -45.1%
H
1.0
7.9
|
L
 -94.6%
H
1.0
106.8
|
L
H
1.0
307.5
|
L
H
1.0
307.5
|
| Caredx Inc |
|
1,401.5
|
27.1
|
L
 8%
H
25.4
27.3
|
L
 16.7%
H
23
27.3
|
L
 25.4%
H
21.3
27.3
|
L
 54.5%
H
15.6
27.3
|
L
 43.2%
H
11.0
27.3
|
L
 244.3%
H
4.8
34.8
|
L
 -71.1%
H
4.8
96.9
|
L
 464.0%
H
0.8
99.8
|
| Celcuity Inc |
|
4,700.1
|
96.4
|
L
 6.8%
H
89.6
96.9
|
L
 10.4%
H
82.6
96.9
|
L
 -30.3%
H
82.6
140.9
|
L
 -9.7%
H
82.6
151.0
|
L
 741.8%
H
11.3
151.0
|
L
 738.1%
H
7.6
151.0
|
L
 281.7%
H
4.8
151.0
|
L
H
4.0
151.0
|
| Creative Medical Tech Holdings Inc |
|
7.4
|
2
|
L
 1.5%
H
1.9
2.0
|
L
 -10.7%
H
1.9
2.3
|
L
 -16.3%
H
1.9
2.5
|
L
 7.5%
H
1.8
2.5
|
L
 -18.0%
H
1.5
6.3
|
L
 -59.0%
H
1.5
10.3
|
L
 -98.9%
H
1.5
200
|
L
 -100.0%
H
1.5
525000
|
| Cerus Corp |
|
529.0
|
2.6
|
L
 1.9%
H
2.6
2.7
|
L
 6.9%
H
2.4
2.7
|
L
 -2.6%
H
2.4
3.1
|
L
 45.1%
H
1.7
3.2
|
L
 97.0%
H
1.2
3.2
|
L
 10%
H
1.1
3.2
|
L
 -53.7%
H
1.1
8.1
|
L
 -58.0%
H
1.1
8.9
|
| Check-Cap Ltd |
|
10.0
|
1.3
|
L
 -5.2%
H
1.3
1.4
|
L
 -5.2%
H
1.3
1.5
|
L
 -27.5%
H
1.3
1.8
|
L
 -24.6%
H
1.3
2.2
|
L
 72%
H
0.6
3.9
|
L
 -59.3%
H
0.6
4.6
|
L
 -96.1%
H
0.6
33.8
|
L
 -99.5%
H
0.6
820.8
|
| CollPlant biotech Ltd - Ordinary Shares New |
|
4.9
|
0.3
|
L
 -2.9%
H
0.3
0.4
|
L
H
0.3
0.4
|
L
 -20.9%
H
0.3
0.5
|
L
 -44.3%
H
0.3
0.9
|
L
 -75.9%
H
0.3
3.2
|
L
 -95.7%
H
0.3
8.9
|
L
 -98.5%
H
0.3
23
|
L
 -98.1%
H
0.3
24.3
|
| ClearPoint Neuro Inc |
|
539.2
|
18.0
|
L
 -3.0%
H
17.8
19.2
|
L
 34.8%
H
16.3
19.2
|
L
 57.2%
H
11.2
19.2
|
L
 89.1%
H
8.3
19.2
|
L
 58.3%
H
8.3
30.1
|
L
 174.1%
H
4.1
30.1
|
L
 -6.1%
H
4.1
30.1
|
L
 119.3%
H
1.3
31.3
|
| Cardiff Oncology Inc |
|
86.1
|
1.3
|
L
 0.8%
H
1.2
1.3
|
L
H
1.2
1.4
|
L
 -29.2%
H
1.2
2
|
L
 -29.2%
H
1.2
2
|
L
 -60.1%
H
1.2
4.6
|
L
 -14.3%
H
0.9
6.4
|
L
 -82.9%
H
0.9
8.6
|
L
 -99.6%
H
0.7
430.6
|
| Castle Biosciences Inc |
|
670.9
|
22.1
|
L
 3.5%
H
21.4
22.5
|
L
 8.1%
H
19.9
22.5
|
L
 9.8%
H
19.5
22.5
|
L
 -14.1%
H
17.7
26.7
|
L
 17.4%
H
14.6
44.3
|
L
 73.9%
H
12.1
44.3
|
L
 -70.4%
H
9.3
78.9
|
L
H
9.3
107.7
|
| Cytek BioSciences Inc |
|
552.7
|
4.3
|
L
 5.2%
H
4.1
4.4
|
L
 4.7%
H
3.7
4.4
|
L
 6.7%
H
3.7
4.5
|
L
 -9.1%
H
3.3
5.0
|
L
 37.2%
H
3.1
6.2
|
L
 -46.7%
H
2.4
9.9
|
L
H
2.4
28.7
|
L
H
2.4
28.7
|
| Cytosorbents Corp |
|
29.5
|
0.5
|
L
 9.3%
H
0.4
0.5
|
L
 -9.6%
H
0.4
0.5
|
L
 2.2%
H
0.4
0.6
|
L
 -29.9%
H
0.4
0.8
|
L
 -62.7%
H
0.4
1.4
|
L
 -86.5%
H
0.4
4.3
|
L
 -94.0%
H
0.4
9.8
|
L
 -89.6%
H
0.4
15.0
|
| Citius Pharma Inc |
|
15.6
|
0.6
|
L
 1.8%
H
0.6
0.6
|
L
 5.6%
H
0.5
0.6
|
L
 -18.6%
H
0.5
0.7
|
L
 -24%
H
0.5
1.0
|
L
 -44.7%
H
0.5
2.5
|
L
 -98.2%
H
0.1
35
|
L
 -99.4%
H
0.1
101.8
|
L
 -99.8%
H
0.1
450.0
|
| CVRx Inc |
|
136.9
|
5.2
|
L
 0.2%
H
5.1
5.3
|
L
 6.0%
H
4.8
5.3
|
L
 -15.6%
H
4.8
6.2
|
L
 -38.7%
H
4.8
9.8
|
L
 -9.8%
H
4.4
11.3
|
L
 -63.8%
H
4.3
33.1
|
L
H
4.3
33.1
|
L
H
4.3
33.1
|
| Delcath Systems Inc |
|
422.5
|
12.2
|
L
 -0.4%
H
12.2
12.8
|
L
 6.1%
H
11.4
12.8
|
L
 11.1%
H
10.2
12.8
|
L
 34.5%
H
8.8
12.8
|
L
 -7.7%
H
8.1
14.2
|
L
 119.7%
H
2.3
18.2
|
L
 17.0%
H
2.3
18.2
|
L
 -100.0%
H
2.3
795025000
|
| Alpha Tau Medical Ltd |
|
907.8
|
10.1
|
L
 2.6%
H
9.8
10.3
|
L
 7.5%
H
9.5
10.3
|
L
 0.1%
H
8.8
11.3
|
L
 39.6%
H
6.4
11.6
|
L
 237.3%
H
2.9
11.6
|
L
 144.5%
H
1.8
11.6
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
| DexCom |
|
26,914.6
|
69.8
|
L
 1.2%
H
68.9
71.1
|
L
 -4.7%
H
68.6
74.3
|
L
 -3.3%
H
68.6
78.9
|
L
 5.8%
H
56.7
78.9
|
L
 -12.6%
H
54.1
90.0
|
L
 -45.0%
H
54.1
142
|
L
 -35.4%
H
54.1
164.9
|
L
 259.5%
H
10.7
164.9
|
| Daxor Corp |
|
61.3
|
10.5
|
L
 3.6%
H
10.0
10.7
|
L
 5%
H
9.4
10.7
|
L
 -3.0%
H
9.3
11.2
|
L
 -0.1%
H
8.6
12.3
|
L
 11.0%
H
8.6
14.8
|
L
 9.4%
H
6.6
14.8
|
L
 -1.0%
H
6.6
14.8
|
L
 33.2%
H
3.4
24.1
|
| ElectroCore Inc |
|
62.8
|
7.6
|
L
 -9.3%
H
7.5
9.0
|
L
 -12.8%
H
7.5
9.0
|
L
 13.5%
H
6.7
10.5
|
L
 23.5%
H
5.6
10.5
|
L
 47.6%
H
4.2
10.5
|
L
 84.6%
H
3.8
19.5
|
L
 -70.3%
H
2.9
26.7
|
L
H
2.9
303.8
|
| ChronoScale Corp |
|
3,166.7
|
22.1
|
L
 -14.3%
H
21.7
25.9
|
L
 15.7%
H
18.9
28.2
|
L
 43.0%
H
14.2
28.2
|
L
 108.8%
H
7.9
28.2
|
L
 684.8%
H
2.7
28.2
|
L
 -92.7%
H
2.7
704.0
|
L
 -98.1%
H
2.7
1323
|
L
 -99.9%
H
2.7
22919.6
|
| Embecta Corp |
|
183.9
|
3.1
|
L
 -1.0%
H
3.1
3.2
|
L
 0.3%
H
3.0
3.3
|
L
 -6.6%
H
3.0
3.5
|
L
 -65.7%
H
2.8
9.9
|
L
 -68.4%
H
2.8
15.6
|
L
 -87.1%
H
2.8
24.1
|
L
H
2.8
63
|
L
H
2.8
63
|
| Establishment Labs Holdings Inc |
|
2,566.6
|
87.2
|
L
 0.2%
H
87.0
89.7
|
L
 5.6%
H
79.6
89.7
|
L
 20.8%
H
65.6
89.7
|
L
 46.3%
H
53.2
89.7
|
L
 138.4%
H
33.4
89.7
|
L
 34.8%
H
17
89.7
|
L
 6.5%
H
17
93.8
|
L
H
7.6
93.8
|
| EDAP TMS S.A. (ADR) |
|
190.4
|
5.1
|
L
 2.0%
H
5.0
5.2
|
L
 7.0%
H
4.7
5.2
|
L
 18.1%
H
4.0
5.2
|
L
 36.2%
H
3.1
5.2
|
L
 195.4%
H
1.2
5.2
|
L
 -42.9%
H
1.2
9.5
|
L
 -27.9%
H
1.2
12.7
|
L
 63.3%
H
1.2
12.7
|
| GlucoTrack Inc |
|
2.2
|
0.4
|
L
 -2.8%
H
0.3
0.4
|
L
 -12.5%
H
0.3
0.4
|
L
 -30%
H
0.3
0.7
|
L
 -67.3%
H
0.3
1.7
|
L
 -94.4%
H
0.3
15.9
|
L
 -100.0%
H
0.3
5940
|
L
 -100.0%
H
0.3
46800
|
L
 -100.0%
H
0.3
468000
|
| GE HealthCare Tech |
|
29,513.4
|
64.9
|
L
 1.8%
H
64.0
65.9
|
L
 2.6%
H
60.0
65.9
|
L
 1.0%
H
60.0
66.4
|
L
 -9.5%
H
58.8
76.0
|
L
 -8.8%
H
58.8
89.8
|
L
 -18.7%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
| Harvard Bioscience Inc |
|
27.4
|
6.1
|
L
 1.2%
H
5.9
6.2
|
L
 2.2%
H
5.8
6.2
|
L
 8.8%
H
5.3
6.7
|
L
 13.9%
H
4.3
7.5
|
L
 18.3%
H
3.8
9.4
|
L
 -89.8%
H
2.8
60
|
L
 -91.7%
H
2.8
87.5
|
L
 -82.5%
H
2.8
87.5
|
| Heart Test Laboratories Inc |
|
8.4
|
2.6
|
L
 -4.4%
H
2.4
2.9
|
L
 39.2%
H
1.7
3.8
|
L
 32.8%
H
1.6
3.8
|
L
 6.5%
H
1.6
3.8
|
L
 -30.6%
H
1.6
6.5
|
L
 -97.2%
H
1.6
100
|
L
H
1.6
600
|
L
H
1.6
600
|
| Helius Medical Tech Inc (Class A) |
|
88.2
|
1.5
|
L
H
1.5
1.6
|
L
 -7.4%
H
1.5
1.7
|
L
 -34.1%
H
1.2
2.3
|
L
 -26.7%
H
1.2
2.4
|
L
 -90.6%
H
1.2
25.5
|
L
 -100.0%
H
1.2
10072.5
|
L
 -100.0%
H
1.2
647250
|
L
 -100.0%
H
1.2
27168750
|
| Henry Schein |
|
9,434.6
|
82.8
|
L
 3.4%
H
80.6
83.2
|
L
 2.0%
H
78.6
83.2
|
L
 11.6%
H
73.6
83.2
|
L
 11.2%
H
68.7
83.2
|
L
 15.2%
H
61.9
89.3
|
L
 5.0%
H
60.0
89.3
|
L
 11.2%
H
60.0
92.7
|
L
 19.0%
H
41.9
92.7
|
| Hyperfine Inc (Class A) |
|
144.9
|
1.5
|
L
 -0.7%
H
1.4
1.5
|
L
 5.8%
H
1.4
1.7
|
L
 -2.0%
H
1.4
1.7
|
L
 20.7%
H
1.0
1.9
|
L
 111.6%
H
0.7
2.2
|
L
 -34.2%
H
0.5
3.3
|
L
 -84.9%
H
0.5
16.6
|
L
H
0.5
16.6
|
| Integra Lifesciences Holdings Corp |
|
1,383.2
|
17.8
|
L
 0.5%
H
17.7
18.3
|
L
 0.4%
H
17.1
18.3
|
L
 17.8%
H
14.7
18.3
|
L
 88.6%
H
8.9
18.3
|
L
 53.0%
H
8.7
18.3
|
L
 -55.0%
H
8.7
46.8
|
L
 -74.9%
H
8.7
76.7
|
L
 -53.9%
H
8.7
77.4
|
| Icecure Medical Ltd |
|
26.1
|
9.3
|
L
 52.0%
H
6
9.4
|
L
 336.6%
H
3.6
9.5
|
L
 31.9%
H
2.1
9.5
|
L
 -51.4%
H
2.1
19.2
|
L
 -66.3%
H
2.1
42
|
L
 -73.5%
H
2.1
49.8
|
L
 -97.1%
H
2.1
372
|
L
 -73.1%
H
2.1
480
|
| SeaStar Medical Holding Corp |
|
12.4
|
3.1
|
L
 -11.0%
H
3.1
3.4
|
L
 1.6%
H
3.0
3.6
|
L
 -17.6%
H
2.6
4.0
|
L
 39.8%
H
2.1
5.1
|
L
 -90.7%
H
2.1
125
|
L
 -99.7%
H
2.1
4292.3
|
L
 -100.0%
H
2.1
55000
|
L
H
2.1
55000
|
| ICU Medical Inc |
|
3,572.8
|
143.0
|
L
 5.5%
H
136.7
143.1
|
L
 0.4%
H
135.1
144.1
|
L
 7.2%
H
129.3
145.3
|
L
 10.0%
H
113.4
145.3
|
L
 11.6%
H
107
160.3
|
L
 -18.9%
H
78.4
196.3
|
L
 -31.0%
H
78.4
282
|
L
 32.2%
H
78.4
321.7
|
| Idexx Laboratories |
|
43,319.4
|
549.2
|
L
 1.5%
H
539.3
560.9
|
L
 -4.2%
H
538.4
573
|
L
 -1.8%
H
538.4
581.5
|
L
 -5.1%
H
523.4
605.8
|
L
 4.7%
H
506.9
770.0
|
L
 12.6%
H
356.3
770.0
|
L
 -10.8%
H
317.1
770.0
|
L
 499.1%
H
86.0
770.0
|
| QTREX Quantum |
|
89.4
|
1.7
|
L
 -10.5%
H
1.7
1.8
|
L
 -18.3%
H
1.7
2.5
|
L
 132.9%
H
1.1
3.9
|
L
 203.6%
H
0.3
3.9
|
L
 123.7%
H
0.3
3.9
|
L
 18.9%
H
0.3
3.9
|
L
H
0.3
9.6
|
L
H
0.3
9.6
|
| Intercure Ltd |
|
57.2
|
1
|
L
 -8.3%
H
1.0
1.1
|
L
 4.2%
H
0.9
1.2
|
L
 13.6%
H
0.9
1.2
|
L
 29.9%
H
0.7
1.2
|
L
 -35.5%
H
0.7
1.8
|
L
 -47.9%
H
0.7
3.7
|
L
 -86.3%
H
0.7
8.8
|
L
H
0.7
19.4
|
| Inogen Inc |
|
183.0
|
6.8
|
L
 3.4%
H
6.5
6.8
|
L
 5.5%
H
6.3
6.8
|
L
 5.6%
H
5.9
6.8
|
L
 4.8%
H
5.9
7.7
|
L
 1.4%
H
5.3
9.1
|
L
 -41.7%
H
4.1
13.3
|
L
 -90.2%
H
4.1
82.4
|
L
 -85.8%
H
4.1
287.8
|
| Inmode Ltd |
|
850.1
|
14.8
|
L
 10.8%
H
14.6
15.2
|
L
 9.6%
H
13.2
15.2
|
L
 7.6%
H
13.2
15.2
|
L
 7.7%
H
13.2
15.2
|
L
 9.6%
H
12.7
16.7
|
L
 -58.9%
H
12.7
48.3
|
L
 -68.8%
H
12.7
99.3
|
L
H
6.5
99.3
|
| NAYA Biosciences |
|
2.2
|
1.3
|
L
 -3.7%
H
1.3
1.4
|
L
 -11.4%
H
1.3
1.6
|
L
 -19.5%
H
1.3
2.1
|
L
 -61.7%
H
1.3
3.6
|
L
 -99.0%
H
1.3
183.6
|
L
 -100.0%
H
1.3
10367.9
|
L
 -100.0%
H
1.3
144000
|
L
 -100.0%
H
1.3
709632
|
| IRIDEX Corp |
|
20.7
|
1.2
|
L
 0.9%
H
1.2
1.2
|
L
H
1.1
1.2
|
L
 17.8%
H
1.0
1.2
|
L
 -11.9%
H
1.0
1.4
|
L
 25.3%
H
0.9
1.7
|
L
 -46.6%
H
0.8
3.7
|
L
 -82.3%
H
0.8
9.5
|
L
 -91.9%
H
0.8
16.6
|
| Iradimed Corp |
|
1,210.0
|
94.7
|
L
 2.5%
H
92.2
96
|
L
 3.1%
H
89.7
96
|
L
 2.8%
H
87.9
98.4
|
L
 -4.6%
H
77.0
103.3
|
L
 59.1%
H
55.1
107.9
|
L
 99.8%
H
36.1
107.9
|
L
 237.3%
H
26
107.9
|
L
 340.7%
H
7.9
107.9
|
| iRhythm Tech Inc |
|
3,696.0
|
112.5
|
L
 2.1%
H
108.5
114.1
|
L
 3.3%
H
100.9
114.1
|
L
 -3.5%
H
100.9
118.7
|
L
 -4.8%
H
100.9
130.0
|
L
 -25.5%
H
100.9
212
|
L
 13.7%
H
55.9
212
|
L
 77.0%
H
41.7
212
|
L
H
22.2
286.2
|
| Intuitive Surgical |
|
142,313.3
|
401.8
|
L
 -0.3%
H
400.1
412.5
|
L
 -3.7%
H
399.3
418.2
|
L
 -8.3%
H
396.7
442.9
|
L
 -15.9%
H
396.7
491.2
|
L
 -22.0%
H
396.7
603.9
|
L
 22.8%
H
254.9
616
|
L
 33.1%
H
180.1
616
|
L
 446.9%
H
67.9
616
|
| Jowell Global Ltd |
|
5.7
|
2.4
|
L
H
2.4
2.4
|
L
 -4.8%
H
2.3
2.7
|
L
 11.6%
H
2.1
3
|
L
 -4%
H
2.0
3
|
L
 29.0%
H
1.5
3
|
L
 -27.5%
H
1
5.6
|
L
 -97.7%
H
1
412.5
|
L
H
1
412.5
|
| Kewaunee Scientific Corp |
|
97.5
|
34
|
L
 -3.6%
H
33.3
35.0
|
L
 -9.3%
H
33.3
38.1
|
L
 -14.9%
H
33.3
41.2
|
L
 -1.5%
H
33.3
41.2
|
L
 -7.9%
H
33.3
60.9
|
L
 100.7%
H
14.6
71.3
|
L
 144.6%
H
12.1
71.3
|
L
 77.8%
H
7.0
71.3
|
| OrthoPediatrics corp |
|
491.6
|
19.1
|
L
 4.1%
H
18.7
19.5
|
L
 3.3%
H
17.7
19.5
|
L
 4.2%
H
16.4
19.5
|
L
 16.2%
H
14.4
19.5
|
L
 -7.0%
H
14.4
23.7
|
L
 -56.5%
H
14.4
46.0
|
L
 -71.2%
H
14.4
73.9
|
L
H
14
73.9
|
| KORU Medical Systems Inc |
|
192.5
|
4.2
|
L
 1.5%
H
4.1
4.3
|
L
 6.4%
H
3.8
4.3
|
L
 2.2%
H
3.8
4.3
|
L
 -5.4%
H
3.8
4.7
|
L
 22.2%
H
2.9
6.6
|
L
 15.1%
H
1.9
6.6
|
L
 3.5%
H
1.8
6.6
|
L
 1063.9%
H
0.3
12.8
|
| Standard BioTools Inc |
|
293.6
|
0.8
|
L
 -5.1%
H
0.8
0.9
|
L
 -9.6%
H
0.8
0.9
|
L
 -27.2%
H
0.8
1.3
|
L
 -22.7%
H
0.8
1.3
|
L
 -39.0%
H
0.8
1.7
|
L
 -62.5%
H
0.8
3.2
|
L
 -87.8%
H
0.8
7.5
|
L
 -92.6%
H
0.8
14.9
|
| LivaNova PLC |
|
4,391.9
|
80.0
|
L
 1.6%
H
78.7
80.9
|
L
 0.6%
H
77.7
80.9
|
L
 8.3%
H
70.7
81.0
|
L
 26.4%
H
56.4
81.0
|
L
 75.4%
H
41.0
81.0
|
L
 64.4%
H
32.5
81.0
|
L
 -7.1%
H
32.5
93.9
|
L
 61.9%
H
32.5
131.5
|
| Lemaitre Vascular Inc |
|
2,108.0
|
92.3
|
L
 0.3%
H
91.8
93.6
|
L
 -1.2%
H
88.6
94.5
|
L
 -5.6%
H
88.6
99.8
|
L
 -14.5%
H
88.6
118.0
|
L
 10.6%
H
79
118.0
|
L
 35.2%
H
44.3
118.0
|
L
 48.0%
H
38.3
118.0
|
L
 522.5%
H
13.5
118.0
|
| LENSAR Inc |
|
73.4
|
6.1
|
L
 5.9%
H
5.7
6.2
|
L
 -1.9%
H
5.6
6.5
|
L
 -0.5%
H
5.5
6.5
|
L
 -0.2%
H
5.1
6.5
|
L
 -50.5%
H
5.1
13.5
|
L
 51.5%
H
1.8
17.3
|
L
 -25.5%
H
1.8
17.3
|
L
H
1.8
17.3
|
| Lantheus Holdings Inc |
|
6,826.4
|
104.9
|
L
 -1.1%
H
104.6
107.3
|
L
 -0.2%
H
101.6
108.0
|
L
 1.8%
H
95
108.0
|
L
 38.5%
H
72.4
108.0
|
L
 29.8%
H
47.3
108.0
|
L
 13.3%
H
47.3
126.9
|
L
 303.7%
H
22.2
126.9
|
L
 3783.3%
H
2.5
126.9
|
| Lucid Diagnostics Inc |
|
194.6
|
1.0
|
L
 -1.0%
H
1.0
1.1
|
L
H
1.0
1.1
|
L
 -4.7%
H
1.0
1.1
|
L
 -18.4%
H
0.9
1.4
|
L
 -14.3%
H
0.9
1.6
|
L
 -25.5%
H
0.6
1.8
|
L
H
0.6
13.5
|
L
H
0.6
13.5
|
| Pulmonx Corp |
|
58.7
|
1.4
|
L
 8.6%
H
1.3
1.4
|
L
 11.2%
H
1.2
1.4
|
L
 -10.3%
H
1.2
1.7
|
L
H
1.1
1.7
|
L
 -45.9%
H
1.1
3.9
|
L
 -89.2%
H
1.1
14.8
|
L
 -96.8%
H
1.1
45.8
|
L
H
1.1
69.5
|
| 908 Devices Inc |
|
339.2
|
9.0
|
L
 2.8%
H
8.6
9.3
|
L
 3.8%
H
8.2
9.3
|
L
 23.2%
H
7.4
9.3
|
L
 46.8%
H
5.7
9.3
|
L
 35.1%
H
5.0
9.3
|
L
 24.1%
H
1.8
12.5
|
L
 -77.4%
H
1.8
41.5
|
L
H
1.8
79.6
|
| Mimedx Grp Inc |
|
570.5
|
3.8
|
L
 2.7%
H
3.7
3.9
|
L
 3.5%
H
3.6
3.9
|
L
 5.8%
H
3.5
3.9
|
L
 -9.7%
H
3.0
4.2
|
L
 -35.5%
H
3.0
8.0
|
L
 -40.6%
H
3.0
10.1
|
L
 -65.4%
H
2.4
16.0
|
L
 -51.7%
H
1.0
18.3
|
| Mesa Laboratories Inc |
|
521.8
|
94.5
|
L
 2.7%
H
92.0
96.6
|
L
 -5.3%
H
87.2
101.3
|
L
 -13.1%
H
81.3
114.0
|
L
 14.6%
H
79.4
114.0
|
L
 -3.5%
H
55.5
114.0
|
L
 -25.7%
H
55.5
155.1
|
L
 -64.3%
H
55.5
333.4
|
L
 -23.4%
H
55.5
333.4
|
| Merit Medical Systems Inc |
|
4,128.1
|
69.2
|
L
 2.9%
H
67.5
69.5
|
L
 2.3%
H
64.5
69.5
|
L
 7.8%
H
60.0
69.5
|
L
 1.6%
H
59.7
71.9
|
L
 -25.0%
H
59.7
96.7
|
L
 -15.8%
H
59.7
111.5
|
L
 10.9%
H
50.5
111.5
|
L
 254.3%
H
18.2
111.5
|
| Modular Medical Inc |
|
22.7
|
4.2
|
L
 -2.1%
H
3.9
5.1
|
L
 -14.5%
H
3.9
5.3
|
L
 -3.2%
H
3.9
5.6
|
L
 -21.4%
H
3.1
6.2
|
L
 -82.1%
H
3.1
30
|
L
 -84.8%
H
3.1
79.5
|
L
 -99.2%
H
3.1
550.4
|
L
 -82.7%
H
3.1
585.0
|
| Myriad Genetics Inc |
|
493.0
|
5.2
|
L
 12.7%
H
4.6
5.2
|
L
 22.8%
H
4.2
5.2
|
L
 36.7%
H
3.7
5.2
|
L
 12.0%
H
3.5
5.4
|
L
 7.4%
H
3.5
8.6
|
L
 -77.1%
H
3.5
29.3
|
L
 -83.5%
H
3.5
37.0
|
L
 -83.0%
H
3.5
50.4
|
| MDxHealth SA (ADR) |
|
-
|
0.5
|
L
 -9.6%
H
0.5
0.6
|
L
 -13.0%
H
0.5
0.6
|
L
 -41.3%
H
0.5
0.8
|
L
 -85.3%
H
0.5
3.2
|
L
 -77.6%
H
0.5
5.3
|
L
 -86.1%
H
0.5
5.3
|
L
H
0.5
13.2
|
L
H
0.5
13.2
|
| ENvue Medical Inc |
|
3.7
|
0.6
|
L
 -4.7%
H
0.6
0.7
|
L
 -20.8%
H
0.6
0.8
|
L
 -39.6%
H
0.6
1.0
|
L
 -57.3%
H
0.6
2.9
|
L
 -93.3%
H
0.6
17.4
|
L
 -99.8%
H
0.6
465.3
|
L
 -100.0%
H
0.6
9218
|
L
 -100.0%
H
0.6
18700
|
| ENDRA Life Sciences Inc |
|
11.6
|
6.3
|
L
 18.1%
H
5.4
6.4
|
L
 33.7%
H
4.4
6.4
|
L
 14.8%
H
4.2
6.4
|
L
 80.2%
H
3.2
6.7
|
L
 91.7%
H
3.0
12.0
|
L
 -91.8%
H
0.0
139.5
|
L
 -99.7%
H
0.0
2350
|
L
H
0.0
5880
|
| Neogen Corp |
|
1,998.2
|
9.2
|
L
 4.0%
H
8.9
9.2
|
L
 -1.4%
H
8.8
9.4
|
L
 3.2%
H
8.6
9.5
|
L
 3.9%
H
8.2
10.8
|
L
 92.5%
H
4.6
11.4
|
L
 -57.7%
H
3.9
24.1
|
L
 -79.7%
H
3.9
47.8
|
L
 -54.0%
H
3.9
48.9
|
| Nephros Inc |
|
36.4
|
3.4
|
L
 1.5%
H
3.3
3.4
|
L
 5.0%
H
3.1
3.4
|
L
 -3.5%
H
3.1
3.8
|
L
 7.7%
H
2.7
3.8
|
L
 -21.9%
H
2.7
6.4
|
L
 105.5%
H
1.3
6.4
|
L
 -63.4%
H
0.9
11.7
|
L
 37.9%
H
0.9
11.7
|
| NeuroOne Medical Tech Corp |
|
28.5
|
3.3
|
L
 -2.4%
H
3.2
3.4
|
L
 0.6%
H
3.1
3.4
|
L
 -11.4%
H
3.1
4.1
|
L
 -29.2%
H
3.1
5.4
|
L
 -17.6%
H
3.1
7.0
|
L
 -48.1%
H
2.4
12
|
L
 -90.7%
H
2.4
42
|
L
H
2.4
180
|
| Nano X Imaging Ltd |
|
109.3
|
1.6
|
L
 4.0%
H
1.5
1.6
|
L
 -8.7%
H
1.5
1.8
|
L
 -14.7%
H
1.5
2.1
|
L
 -35.7%
H
1.5
3.1
|
L
 -68.3%
H
1.5
5.7
|
L
 -90.1%
H
1.5
16.5
|
L
 -94.9%
H
1.5
34.5
|
L
H
1.5
94.8
|
| NeuroPace Inc |
|
553.0
|
16.2
|
L
 1.9%
H
16.0
16.8
|
L
 8.0%
H
14.9
16.8
|
L
 -4.1%
H
14.9
17.7
|
L
 21.2%
H
12.5
19.6
|
L
 53.5%
H
7.6
19.6
|
L
 262.1%
H
3.9
19.6
|
L
 -34.8%
H
1.2
25.3
|
L
H
1.2
27.4
|
| InspireMD Inc |
|
32.8
|
0.7
|
L
H
0.7
0.7
|
L
 -1.4%
H
0.7
0.8
|
L
 -30%
H
0.7
1.0
|
L
 -59.8%
H
0.7
1.8
|
L
 -72.2%
H
0.7
2.9
|
L
 -67.3%
H
0.7
3.9
|
L
 -86.6%
H
0.7
6.8
|
L
 -100.0%
H
0.7
275625
|
| Nortech Systems Inc |
|
45.1
|
16.1
|
L
 -3.9%
H
15.7
17.1
|
L
 0.5%
H
15.5
17.6
|
L
 32.0%
H
12.3
18.0
|
L
 60.1%
H
9.9
18.0
|
L
 92.8%
H
6.5
18.0
|
L
 75.1%
H
6.5
19.2
|
L
 119.0%
H
6.5
19.6
|
L
 342.2%
H
1.7
19.6
|
| Natera Inc |
|
37,231.7
|
260.0
|
L
 10.7%
H
239
264.7
|
L
 18.1%
H
217.7
264.7
|
L
 27.9%
H
196.4
264.7
|
L
 29.9%
H
181
264.7
|
L
 52.6%
H
131.8
264.7
|
L
 406.1%
H
36.9
264.7
|
L
 126.1%
H
26.1
264.7
|
L
 1808.7%
H
7.4
264.7
|
| Nutriband Inc |
|
38.2
|
3.1
|
L
 3.0%
H
3.1
3.2
|
L
 -5.1%
H
2.9
3.4
|
L
 -13.7%
H
2.9
3.7
|
L
 -18.2%
H
2.9
4.3
|
L
 -59.3%
H
2.9
11.7
|
L
 37.1%
H
1.5
11.8
|
L
 -72.9%
H
1.5
12.9
|
L
H
0.9
43.5
|
| Nuwellis Inc |
|
1.1
|
0.1
|
L
 -30.8%
H
0.1
0.1
|
L
 -35.7%
H
0.1
0.1
|
L
 -91.4%
H
0.1
1.0
|
L
 -91.9%
H
0.1
1.3
|
L
 -99.3%
H
0.1
26.0
|
L
 -100.0%
H
0.1
4189.5
|
L
 -100.0%
H
0.1
779100
|
L
 -100.0%
H
0.1
10000000000
|
| NovoCure Ltd |
|
1,704.9
|
14.7
|
L
 4.2%
H
14.2
15.1
|
L
 -15.8%
H
13.4
18
|
L
 -18.0%
H
13.4
18.7
|
L
 24.5%
H
10.1
18.9
|
L
 -11.4%
H
9.8
18.9
|
L
 -64.8%
H
9.8
42.7
|
L
 -93.5%
H
9.8
232.8
|
L
 34.3%
H
6.0
232.8
|
| enVVeno Medical Corp |
|
7.6
|
11.4
|
L
 16.1%
H
10.2
11.4
|
L
 7.9%
H
9.8
11.4
|
L
 3.7%
H
9.7
11.4
|
L
 8.2%
H
9.0
13.4
|
L
 -92.0%
H
8.7
196.7
|
L
 -87.7%
H
8.7
244.0
|
L
 -94.8%
H
8.7
398.3
|
L
H
8.7
4935
|
| Nexalin Tech Inc |
|
7.3
|
0.3
|
L
 -5.6%
H
0.3
0.4
|
L
 -12.8%
H
0.3
0.4
|
L
 -10.5%
H
0.3
0.6
|
L
 -17.1%
H
0.3
0.6
|
L
 -67.6%
H
0.3
2
|
L
 -62.2%
H
0.3
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
| Nyxoah SA |
|
161.9
|
1.6
|
L
 3.2%
H
1.6
1.6
|
L
 2.5%
H
1.5
1.7
|
L
 -43.6%
H
1.3
3.1
|
L
 -48.7%
H
1.3
3.6
|
L
 -79.3%
H
1.3
8.6
|
L
 -79.6%
H
1.3
20
|
L
 -94%
H
1.3
37
|
L
H
1.3
37
|
| Nanobiotix (ADR) |
|
1,744.5
|
34.4
|
L
 -6.2%
H
33.4
36.0
|
L
 -4.6%
H
33.4
38
|
L
 -16.2%
H
31.7
42.9
|
L
 12.5%
H
28.4
57.1
|
L
 677.2%
H
4.4
57.1
|
L
 526.8%
H
2.8
57.1
|
L
 138.2%
H
1.8
57.1
|
L
H
1.8
57.1
|
| Orchestra BioMed Holdings Inc |
|
238.3
|
4.0
|
L
 -1.5%
H
4.0
4.1
|
L
 3.4%
H
3.8
4.1
|
L
 -2.0%
H
3.8
4.2
|
L
 -16.4%
H
3.7
4.8
|
L
 28.4%
H
2.2
5.4
|
L
 -52.4%
H
2.2
11.7
|
L
 -60.6%
H
2.2
23.4
|
L
H
2.2
23.4
|
| Orthofix Medical Inc |
|
378.3
|
9.4
|
L
 2.9%
H
9.1
9.6
|
L
 -0.5%
H
8.9
9.9
|
L
 -12.9%
H
8.9
10.7
|
L
 -21.2%
H
8.9
13.0
|
L
 -13.3%
H
8.9
17.0
|
L
 -49.1%
H
8.9
21.6
|
L
 -77.0%
H
8.9
43.3
|
L
 -78.8%
H
8.9
74.4
|
| Outset Medical Inc |
|
85.8
|
4.6
|
L
 -2.7%
H
4.6
5.0
|
L
 5.0%
H
4
5.3
|
L
 7.2%
H
4
5.4
|
L
 27.9%
H
3.3
5.4
|
L
 -73.3%
H
3
21.4
|
L
 -98.6%
H
0.5
337.1
|
L
 -99.4%
H
0.5
905.0
|
L
H
0.5
1004.4
|
| Organogenesis Holdings Inc (Class A) |
|
314.0
|
2.4
|
L
 0.4%
H
2.4
2.5
|
L
 1.7%
H
2.3
2.5
|
L
 -8.3%
H
2.2
2.7
|
L
 -1.2%
H
2.0
2.8
|
L
 -27.0%
H
2.0
7.1
|
L
 -28.7%
H
2.0
7.1
|
L
 -85.5%
H
1.8
17.5
|
L
H
1.8
310.9
|
| Orasure Tech Inc |
|
298.8
|
4.3
|
L
 2.4%
H
4.2
4.4
|
L
 0.5%
H
4.1
4.6
|
L
 20.2%
H
3.7
4.6
|
L
 40.9%
H
2.8
4.6
|
L
 43.2%
H
2.1
4.6
|
L
 -15.1%
H
2.1
8.5
|
L
 -54.9%
H
2.1
13.6
|
L
 -36.3%
H
2.1
23.0
|
| Pacific Biosciences of California Inc |
|
447.3
|
1.4
|
L
 9.9%
H
1.3
1.5
|
L
 6.7%
H
1.3
1.5
|
L
 18.0%
H
1.2
1.8
|
L
 3.6%
H
1.1
1.8
|
L
 21.0%
H
1.1
2.7
|
L
 -88.5%
H
0.9
14.6
|
L
 -95.4%
H
0.9
36.4
|
L
 -83.3%
H
0.9
53.7
|
| PAVmed Inc |
|
33.4
|
4.7
|
L
 -0.2%
H
4.6
4.7
|
L
 -6.2%
H
3.9
5.7
|
L
 -26.9%
H
3.9
6.5
|
L
 -52.5%
H
3.9
10.2
|
L
 -74.6%
H
3.9
28.4
|
L
 -97.3%
H
3.9
270
|
L
 -99.8%
H
3.9
4365
|
L
H
3.9
6858
|
| Pro-Dex Inc (co) |
|
206.6
|
64.7
|
L
 2.1%
H
63.4
67
|
L
 3.9%
H
60.0
67
|
L
 1.9%
H
59.1
69.0
|
L
 35.0%
H
43.3
69.0
|
L
 54.8%
H
23.5
69.0
|
L
 238.0%
H
14.5
70.3
|
L
 120.5%
H
12.4
70.3
|
L
 1202.2%
H
3.8
70.3
|
| Pulse Biosciences Inc |
|
1,771.8
|
25.6
|
L
 -1.4%
H
25.3
27.1
|
L
 2.0%
H
24.8
27.1
|
L
 -1.1%
H
23.6
28.5
|
L
 22.3%
H
17.8
28.5
|
L
 65.3%
H
12.6
28.5
|
L
 300%
H
3.8
28.5
|
L
 40.8%
H
1.2
29.2
|
L
 468.9%
H
1.2
45.8
|
| Axe Compute Inc |
|
70.0
|
6.5
|
L
 -1.8%
H
6.3
6.7
|
L
 -12.6%
H
5.9
7.7
|
L
 21.2%
H
5.4
9
|
L
 296.9%
H
1.0
10.9
|
L
 -49.6%
H
1.0
32.1
|
L
 -89.7%
H
1.0
106.8
|
L
 -97.9%
H
1.0
439.8
|
L
 -99.9%
H
1.0
20250
|
| Precision Optics Corp Inc |
|
56.3
|
5.1
|
L
 -2.3%
H
5.0
5.4
|
L
 -12.9%
H
5.0
6.1
|
L
 4.3%
H
4.8
6.2
|
L
 17.4%
H
3.6
6.2
|
L
 10.8%
H
3.6
6.2
|
L
 -18.2%
H
3.5
6.9
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
| Insulet |
|
10,312.1
|
148.9
|
L
 3.5%
H
144.8
149.6
|
L
 0.8%
H
138.8
150.8
|
L
 -3.9%
H
138.8
161.4
|
L
 -34.4%
H
138.8
228.0
|
L
 -51.6%
H
138.8
354.9
|
L
 -48.3%
H
125.8
354.9
|
L
 -46.9%
H
125.8
354.9
|
L
 405.5%
H
27.6
354.9
|
| Procept BioRobotics Corp |
|
1,186.8
|
20.9
|
L
 1.2%
H
20.8
22.0
|
L
 -5.7%
H
19.9
22.6
|
L
 -28.1%
H
19.9
29.7
|
L
 -19.9%
H
19.9
29.7
|
L
 -64.5%
H
19.4
62.2
|
L
 -37.3%
H
19.4
103.8
|
L
H
15.4
103.8
|
L
H
15.4
103.8
|
| Prenetics Global Ltd (Class A) |
|
335.2
|
19.7
|
L
 -1%
H
19.3
20.4
|
L
 -3.9%
H
19.2
20.8
|
L
 17.6%
H
16.8
22.2
|
L
 -8.1%
H
14
23.6
|
L
 142.6%
H
7.2
23.6
|
L
 45.6%
H
2.9
23.6
|
L
H
2.9
131.3
|
L
H
2.9
131.3
|
| Profound Medical Corp |
|
236.6
|
6.5
|
L
 -0.2%
H
6.5
6.8
|
L
 -3.3%
H
6.4
7.0
|
L
 -4.7%
H
6.3
7
|
L
 20.6%
H
5.1
7.9
|
L
 8.3%
H
3.8
9.0
|
L
 -49.8%
H
3.8
13.5
|
L
 -64.4%
H
3.1
19
|
L
 -36.1%
H
0.0
29.0
|
| QuidelOrtho Corporation |
|
832.6
|
12.2
|
L
 2.3%
H
11.8
12.7
|
L
 -13.5%
H
11.8
14.4
|
L
 3.0%
H
11.7
15.8
|
L
 -26.2%
H
9.9
18
|
L
 -55.8%
H
9.9
35.6
|
L
 -85.5%
H
9.9
89.1
|
L
 -89.2%
H
9.9
180.1
|
L
 -31.6%
H
9.9
306.7
|
| Quanterix Corp |
|
178.1
|
3.8
|
L
 17.4%
H
3.3
3.8
|
L
 23.5%
H
2.8
3.8
|
L
 40.5%
H
2.6
4.0
|
L
 -4.1%
H
2.4
4.1
|
L
 -40%
H
2.4
8.8
|
L
 -83.1%
H
2.4
29.7
|
L
 -94.0%
H
2.4
66.2
|
L
H
2.4
92.6
|
| AVITA Medical Inc |
|
121.6
|
4.0
|
L
 0.8%
H
3.9
4.0
|
L
 0.8%
H
3.8
4.2
|
L
 -13.8%
H
3.8
4.7
|
L
H
3.5
5.9
|
L
 -23.2%
H
3.2
7.1
|
L
 -75.6%
H
3.2
21.7
|
L
 -81.4%
H
3.2
22.5
|
L
 -47.3%
H
3.2
55.4
|
| Rockwell Medical Inc |
|
26.8
|
0.7
|
L
 1.5%
H
0.7
0.7
|
L
H
0.6
0.7
|
L
 -13.9%
H
0.6
0.8
|
L
 -33.3%
H
0.6
1.1
|
L
 -21.8%
H
0.6
2.1
|
L
 -84.6%
H
0.6
6.2
|
L
 -92.9%
H
0.6
10.8
|
L
 -99.2%
H
0.6
98.8
|
| Vyome Holdings Inc |
|
14.7
|
2.1
|
L
 -0.9%
H
2.1
2.2
|
L
 -4.6%
H
2.1
2.4
|
L
 -5.8%
H
2.1
2.5
|
L
 -9.5%
H
1.8
2.5
|
L
 -18.0%
H
1.8
12.9
|
L
 -97.8%
H
0.3
105.0
|
L
 -100.0%
H
0.3
23345
|
L
H
0.3
1381560
|
| Rewalk Robotics Ltd |
|
417.2
|
6.9
|
L
 -0.1%
H
6.8
7.2
|
L
 0.3%
H
6.8
7.2
|
L
 -1.6%
H
6.2
8
|
L
 7.1%
H
6.0
8
|
L
 638.3%
H
0.4
8
|
L
 70.9%
H
0.4
9.1
|
L
 -44.0%
H
0.4
19.5
|
L
 -99.4%
H
0.4
1373.8
|
| Sanmina Corp |
|
13,335.7
|
248.8
|
L
 0.7%
H
243
260.2
|
L
 -0.1%
H
236.7
260.2
|
L
 1.0%
H
229.1
288.7
|
L
 89.4%
H
122.2
288.7
|
L
 171.3%
H
91.8
288.7
|
L
 338.0%
H
43.4
288.7
|
L
 548.1%
H
35.1
288.7
|
L
 783.6%
H
18.3
288.7
|
| Sight Sciences Inc |
|
299.3
|
5.5
|
L
 1.7%
H
5.4
5.8
|
L
 9.6%
H
4.9
5.8
|
L
 9.3%
H
4.2
5.8
|
L
 51.5%
H
3.4
5.8
|
L
 26.7%
H
3.1
9.2
|
L
 -29.9%
H
1.0
9.3
|
L
H
1.0
42.6
|
L
H
1.0
42.6
|
| Sotera Health Co |
|
4,759.4
|
16.7
|
L
 5.4%
H
16.0
16.8
|
L
 4.1%
H
15.4
16.8
|
L
 6.6%
H
14.8
16.8
|
L
 20.2%
H
13.1
16.8
|
L
 50.5%
H
10.9
19.9
|
L
 -7.2%
H
9.5
19.9
|
L
 -29.7%
H
5.8
27.4
|
L
H
5.8
30.4
|
| SI-BONE Inc |
|
724.7
|
16.3
|
L
 2.5%
H
15.6
16.7
|
L
 6.0%
H
15.2
16.7
|
L
 11.3%
H
13.4
16.7
|
L
 25.8%
H
11.5
16.7
|
L
 -1.1%
H
11.5
21.9
|
L
 -43.4%
H
11.5
29.2
|
L
 -48.0%
H
11.1
34.4
|
L
H
7.2
37.2
|
| SINTX Tech Inc |
|
12.2
|
2.0
|
L
 2.1%
H
1.9
2.1
|
L
 -9.3%
H
1.9
2.2
|
L
 -18.0%
H
1.9
2.5
|
L
 -23.1%
H
1.9
3
|
L
 -36.2%
H
1.9
6.8
|
L
 -99.3%
H
0.1
364
|
L
 -100.0%
H
0.1
41100
|
L
 -100.0%
H
0.1
11664000
|
| Beauty Health Co (Class A) |
|
85.5
|
0.7
|
L
 -1.5%
H
0.7
0.7
|
L
 1.5%
H
0.6
0.7
|
L
 -4.4%
H
0.6
0.9
|
L
 -43.1%
H
0.6
1.1
|
L
 -65.8%
H
0.6
2.7
|
L
 -91.5%
H
0.6
9.0
|
L
 -96.3%
H
0.6
30.2
|
L
H
0.6
30.2
|
| Sanara MedTech Inc |
|
209.8
|
22.9
|
L
 5.2%
H
21.8
23.0
|
L
 0.9%
H
20.4
23.7
|
L
 -1.2%
H
20.4
23.9
|
L
 24.8%
H
16.1
24.3
|
L
 -17.7%
H
16.1
36.0
|
L
 -43.5%
H
16.1
46.4
|
L
 -29.0%
H
16.1
50.2
|
L
 281.5%
H
2
75
|
| Sensus Healthcare Inc |
|
49.9
|
3.0
|
L
 10.6%
H
2.7
3.0
|
L
 11.8%
H
2.7
3.0
|
L
 -5.0%
H
2.7
3.3
|
L
 -26.3%
H
2.7
4.6
|
L
 -34.1%
H
2.7
5.9
|
L
 9.0%
H
1.8
9.3
|
L
 -31.3%
H
1.8
15.3
|
L
H
1.8
15.3
|
| Staar Surgical Co. |
|
1,439.9
|
28.9
|
L
 2.0%
H
28.1
29.1
|
L
H
27.9
29.6
|
L
 -10.9%
H
27.9
33.9
|
L
 56.2%
H
17.5
35.9
|
L
 73.4%
H
15.6
35.9
|
L
 -43.2%
H
13.5
58.8
|
L
 -81.1%
H
13.5
163.1
|
L
 414.6%
H
5.1
163.1
|
| Neuronetics Inc |
|
87.7
|
1.3
|
L
 3.3%
H
1.2
1.4
|
L
 5%
H
1.2
1.4
|
L
 5%
H
1.2
1.7
|
L
 -21.3%
H
1.1
2.5
|
L
 -63.3%
H
0.8
4.9
|
L
 -39.7%
H
0.5
5.9
|
L
 -92.5%
H
0.5
17.9
|
L
H
0.5
39.4
|
| Star Equity Holdings Inc |
|
35.6
|
11.0
|
L
 0.2%
H
11.0
11.3
|
L
 -0.1%
H
11.0
11.5
|
L
 -3.8%
H
10.1
11.9
|
L
 13.9%
H
9
11.9
|
L
 463.3%
H
1.9
12.0
|
L
 64.8%
H
1.7
12.0
|
L
 -20.6%
H
1.7
23.4
|
L
 -95.8%
H
1.7
307.5
|
| SkyAI Inc |
|
43.2
|
1.0
|
L
 -1.0%
H
1.0
1.0
|
L
 -20.9%
H
1.0
1.3
|
L
 -43.7%
H
1.0
2.0
|
L
 -44.3%
H
1.0
2.1
|
L
 -80.9%
H
1.0
18.2
|
L
 -100.0%
H
0.0
6204
|
L
H
0.0
23892
|
L
H
0.0
23892
|
| Tactile Systems Tech Inc |
|
620.1
|
27.5
|
L
 3.9%
H
25.2
27.6
|
L
 4.0%
H
25.2
27.6
|
L
 10.4%
H
23.8
27.6
|
L
 3.7%
H
20.5
27.8
|
L
 170.3%
H
9.4
37.8
|
L
 16.8%
H
8.6
37.8
|
L
 -49.4%
H
6.3
57.6
|
L
H
6.3
76.6
|
| TELA Bio Inc |
|
33.6
|
0.8
|
L
 -5.1%
H
0.7
0.9
|
L
 -16.7%
H
0.7
0.9
|
L
 -15.7%
H
0.7
1.0
|
L
 -9.6%
H
0.5
1.3
|
L
 -56.7%
H
0.5
2.2
|
L
 -92.8%
H
0.5
10.8
|
L
 -95.2%
H
0.5
16.5
|
L
H
0.5
23.5
|
| Valion Bio Inc |
|
1.7
|
0.5
|
L
 1.9%
H
0.5
0.6
|
L
 -3.6%
H
0.5
0.6
|
L
 -36.5%
H
0.5
1.0
|
L
 -45.5%
H
0.5
1.4
|
L
 -86.1%
H
0.5
5.6
|
L
 -99.7%
H
0.5
369.8
|
L
H
0.5
11050
|
L
H
0.5
11050
|
| Treace Medical Concepts Inc |
|
267.9
|
4.1
|
L
 -8.0%
H
4.0
4.7
|
L
 0.2%
H
3.9
4.7
|
L
 48.6%
H
2.7
4.7
|
L
 227.8%
H
1.2
4.7
|
L
 -28.1%
H
1.2
7.8
|
L
 -83.8%
H
1.2
25.8
|
L
 -87.4%
H
1.2
33.6
|
L
H
1.2
37.2
|
| Transmedics Grp Inc |
|
2,682.6
|
77.6
|
L
 5.1%
H
75.0
78.3
|
L
 2.4%
H
72.8
80.7
|
L
 12.6%
H
64.9
80.7
|
L
 -30.8%
H
60.1
120.9
|
L
 -39.1%
H
60.1
156
|
L
 -3.1%
H
36.4
177.4
|
L
 155.2%
H
10
177.4
|
L
H
10
177.4
|
| Tandem Diabetes Care Inc |
|
1,029.3
|
15.0
|
L
 4.2%
H
14.4
15.3
|
L
 -10.0%
H
14.0
17.1
|
L
 0.4%
H
14.0
20.6
|
L
 -40.1%
H
12.3
25.1
|
L
 -25.7%
H
10.0
29.7
|
L
 -39.9%
H
10.0
53.7
|
L
 -84.4%
H
10.0
155.9
|
L
 -79.2%
H
2.1
155.9
|
| Trinity Biotech PLC (ADR) |
|
6.9
|
0.3
|
L
 -5.6%
H
0.3
0.4
|
L
 -40.4%
H
0.3
0.6
|
L
 -43.3%
H
0.3
0.8
|
L
 -43.3%
H
0.3
0.8
|
L
 -97.5%
H
0.3
86
|
L
 -99.9%
H
0.3
687.5
|
L
 -100.0%
H
0.3
1906.3
|
L
 -100.0%
H
0.3
8550
|
| Utah Medical Products Inc |
|
211.6
|
66.5
|
L
 1.9%
H
65.6
67.7
|
L
 -1.0%
H
64.8
67.7
|
L
 3.0%
H
64.2
70.5
|
L
 2.1%
H
60.9
71.8
|
L
 21.1%
H
53.7
71.8
|
L
 -24.3%
H
51.3
99.5
|
L
 -22.2%
H
51.3
133.9
|
L
 3.4%
H
51.3
133.9
|
| Vivani Medical Inc |
|
105.2
|
1.2
|
L
 2.5%
H
1.2
1.2
|
L
 4.3%
H
1.1
1.2
|
L
 1.7%
H
1.1
1.3
|
L
 3.4%
H
0.9
1.5
|
L
 -3.2%
H
0.9
1.9
|
L
 -3.2%
H
0.8
7.8
|
L
 -92.1%
H
0.8
16.2
|
L
 -98.7%
H
0.8
109.2
|
| Veracyte Inc |
|
4,529.0
|
56.8
|
L
 5.5%
H
54.4
58.1
|
L
 11.5%
H
50.5
58.1
|
L
 26.1%
H
43.1
58.1
|
L
 69.2%
H
29.5
58.1
|
L
 112.5%
H
22.6
58.1
|
L
 122.3%
H
18.6
58.1
|
L
 45.2%
H
14.9
58.1
|
L
 981.1%
H
4.8
86.0
|
| Varex Imaging Corp |
|
437.1
|
10.4
|
L
 -1.4%
H
10.3
11.0
|
L
 -1.2%
H
10.1
11.0
|
L
 3.0%
H
9.7
11.7
|
L
 -4.2%
H
9.1
12.8
|
L
 32.4%
H
6.8
14.6
|
L
 -54.4%
H
6.8
23.9
|
L
 -61.5%
H
6.8
32.7
|
L
H
6.8
43.8
|
| Vivos Therapeutics Inc |
|
6.1
|
0.4
|
L
 -6.4%
H
0.4
0.5
|
L
 -18.5%
H
0.4
0.6
|
L
 -27.9%
H
0.4
1.4
|
L
 -62.7%
H
0.4
1.5
|
L
 -85.0%
H
0.4
8.0
|
L
 -96.4%
H
0.4
48.8
|
L
 -99.6%
H
0.4
177.3
|
L
H
0.4
360.3
|
| Wrap Tech Inc |
|
62.4
|
1.1
|
L
 -5.9%
H
1.1
1.2
|
L
 -8.2%
H
1.1
1.3
|
L
 -23.3%
H
1.1
1.5
|
L
 -22.8%
H
1.1
1.7
|
L
 -28.2%
H
1.1
3.2
|
L
 -20.6%
H
1.1
7.0
|
L
 -87.4%
H
1.0
8.9
|
L
H
1.0
14.4
|
| Beyond Air Inc |
|
6.1
|
0.5
|
L
 2.1%
H
0.5
0.5
|
L
 37.1%
H
0.3
0.5
|
L
 20%
H
0.3
0.5
|
L
 -40.7%
H
0.3
0.8
|
L
 -87.4%
H
0.3
4.8
|
L
 -99.5%
H
0.3
96.7
|
L
 -99.6%
H
0.3
328.2
|
L
H
0.3
900
|
| DENTSPLY Sirona Inc |
|
2,107.4
|
10.5
|
L
 3.1%
H
10.3
10.7
|
L
 0.7%
H
10.0
10.9
|
L
 3.0%
H
9.5
10.9
|
L
 -8.8%
H
9.4
13.0
|
L
 -32.0%
H
9.4
17.1
|
L
 -72.6%
H
9.4
41.6
|
L
 -83.6%
H
9.4
67.0
|
L
 -83.6%
H
9.4
69.5
|
| X.T.L. Biopharma Ltd (ADR) |
|
6.6
|
2.8
|
L
H
2.5
2.8
|
L
 17.2%
H
2.3
2.8
|
L
 11.2%
H
2.0
2.8
|
L
 19.7%
H
2.0
4.9
|
L
 -82.9%
H
2.0
41.1
|
L
 -85.5%
H
2.0
79.8
|
L
 -94.9%
H
2.0
107.0
|
L
 -97.0%
H
2.0
125.6
|
| 111 Inc (ADR) |
|
35.3
|
4.0
|
L
 -6.5%
H
4.0
4.5
|
L
 -9.9%
H
3.7
4.7
|
L
 -29.7%
H
3.7
5.8
|
L
 -40.2%
H
3.7
7.3
|
L
 -47.8%
H
2.5
11.2
|
L
 57.9%
H
0.4
11.3
|
L
 -54.3%
H
0.4
11.3
|
L
H
0.4
45.9
|
| Jin Medical Intl Ltd |
|
19.3
|
2.5
|
L
 0.4%
H
2.4
2.5
|
L
 2.9%
H
2.4
2.5
|
L
 3.4%
H
2.0
4.5
|
L
 21.8%
H
1.6
4.5
|
L
 -80.9%
H
1.6
17.2
|
L
 -77.2%
H
1.6
509.9
|
L
H
1.6
509.9
|
L
H
1.6
509.9
|
| HeartBeam Inc |
|
38.3
|
0.7
|
L
H
0.7
0.7
|
L
 -4.2%
H
0.7
0.8
|
L
 -21.6%
H
0.7
0.9
|
L
 -40%
H
0.7
1.3
|
L
 -53.1%
H
0.5
4
|
L
 -56.3%
H
0.5
4
|
L
 -56.3%
H
0.5
4
|
L
 -56.3%
H
0.5
4
|
| Cencora |
|
55,346.8
|
284.5
|
L
 1.2%
H
281.1
288.5
|
L
 1.1%
H
269.3
288.5
|
L
 3.5%
H
261.3
288.5
|
L
 -11.3%
H
244.8
329.0
|
L
 -3.0%
H
244.8
377.5
|
L
 51.6%
H
171.7
377.5
|
L
 145.6%
H
111.3
377.5
|
L
 266.8%
H
68.4
377.5
|
| Incannex Healthcare Ltd (ADR) |
|
38.9
|
3.3
|
L
 -1.8%
H
3.1
3.3
|
L
 -12.9%
H
3.1
4.0
|
L
 -7.7%
H
2.8
4.2
|
L
 5.9%
H
2.5
5
|
L
 -45.8%
H
2.5
49.8
|
L
 -98.0%
H
2.4
160.2
|
L
 -98.0%
H
2.4
160.2
|
L
 -98.0%
H
2.4
160.2
|
| Rewalk Robotics Ltd |
|
19.5
|
6.9
|
L
 -0.1%
H
6.8
7.2
|
L
 0.3%
H
6.8
7.2
|
L
 -1.6%
H
6.2
8
|
L
 7.1%
H
6.0
8
|
L
 -38.4%
H
4.1
12
|
L
 -85.7%
H
4.1
109.2
|
L
 -95.3%
H
4.1
233.5
|
L
 -100.0%
H
4.1
16485
|
| Work Medical Tech Grp Ltd |
|
5.9
|
2.5
|
L
 -6.1%
H
2.2
2.6
|
L
 -51.8%
H
1.8
5.7
|
L
 -78.0%
H
1.8
18.7
|
L
 -97.8%
H
1.8
733
|
L
 -100%
H
1.8
930000
|
L
H
1.8
8446000
|
L
H
1.8
8446000
|
L
H
1.8
8446000
|
| iTonic Holdings Ordinary |
|
5.5
|
0.3
|
L
H
0.3
0.4
|
L
 -8.6%
H
0.3
0.4
|
L
 3.2%
H
0.3
1.2
|
L
 10.3%
H
0.3
1.2
|
L
 -98.4%
H
0.3
32
|
L
H
0.3
32
|
L
H
0.3
32
|
L
H
0.3
32
|
| Ceribell Inc |
|
706.1
|
18.6
|
L
 1.2%
H
18.5
19.4
|
L
 3.9%
H
17.1
19.4
|
L
 -0.9%
H
17.0
19.4
|
L
 -2.1%
H
15.8
21.7
|
L
 0.7%
H
10.9
24.3
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
| Anteris Tech Global Corp |
|
1,012.4
|
10.4
|
L
 1.2%
H
9.9
10.4
|
L
 12.2%
H
9.3
10.6
|
L
 8.1%
H
8.4
10.6
|
L
 90.1%
H
5.0
10.6
|
L
 173.7%
H
2.9
10.6
|
L
H
2.3
10.6
|
L
H
2.3
10.6
|
L
H
2.3
10.6
|
| Beta Bionics Inc |
|
656.4
|
14.7
|
L
 7.8%
H
13.8
15.0
|
L
 5.6%
H
13.0
15.0
|
L
 24.6%
H
11.3
15.0
|
L
 33.7%
H
8.8
15.0
|
L
 -6.8%
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
| Wellgistics Health Inc |
|
7.1
|
2.8
|
L
 -9.6%
H
2.8
3.2
|
L
 -23.6%
H
2.8
3.9
|
L
 -31.9%
H
2.8
4.5
|
L
 -55.2%
H
2.8
11.6
|
L
 -94.7%
H
2.8
94.5
|
L
H
2.8
352
|
L
H
2.8
352
|
L
H
2.8
352
|
| Kestra Medical Tech Ltd |
|
1,288.9
|
22.1
|
L
 6.7%
H
20.6
22.7
|
L
 14.8%
H
18.5
22.7
|
L
 2.0%
H
17.9
22.7
|
L
 12.7%
H
17.3
24.5
|
L
 38%
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
| Sanuwave Health Inc |
|
73.7
|
8.6
|
L
 4.5%
H
8.2
9.1
|
L
 0.7%
H
8.2
9.9
|
L
 -48.7%
H
8.2
17.1
|
L
 -58.2%
H
8.2
21.2
|
L
 -74.5%
H
8.2
46.6
|
L
 -73.5%
H
8.2
46.6
|
L
 -73.5%
H
8.2
46.6
|
L
 -73.5%
H
8.2
46.6
|
| SS Innovations Intl Inc |
|
704.5
|
3.5
|
L
 3.5%
H
3.3
3.8
|
L
 1.4%
H
3.2
3.8
|
L
 -9.5%
H
3.2
4.4
|
L
 -28.2%
H
3.2
5.1
|
L
 -37.7%
H
3.1
10
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
| Medline Inc Ordinary Shares |
|
30,484.1
|
36.1
|
L
 2.1%
H
35.3
37.1
|
L
 -2.8%
H
34.6
37.2
|
L
 -2.6%
H
32.8
37.8
|
L
 -15.1%
H
32.8
49.1
|
L
 -12.1%
H
32.8
50.9
|
L
 -12.1%
H
32.8
50.9
|
L
 -12.1%
H
32.8
50.9
|
L
 -12.1%
H
32.8
50.9
|
| FocalTherics ADR |
|
-
|
5.1
|
L
 2.0%
H
5.0
5.2
|
L
 7.0%
H
4.7
5.2
|
L
 11.4%
H
4.5
5.2
|
L
 11.4%
H
4.5
5.2
|
L
 11.4%
H
4.5
5.2
|
L
 11.4%
H
4.5
5.2
|
L
 11.4%
H
4.5
5.2
|
L
 11.4%
H
4.5
5.2
|